| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
262 |
| issn |
1618-7598
1618-7601 |
| issueIdentifier |
4 |
| pageRange |
254-262 |
| publicationName |
The European journal of health economics : HEPAC : health economics in prevention and care |
| startingPage |
254 |
| bibliographicCitation |
Lundkvist J, Bergqvist D, J�nsson B. Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden. The European Journal of Health Economics. 2003 Dec 01;4(4):254–62. doi: 10.1007/s10198-003-0175-4. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_558b4e82aea1e1c84084ce8d39dc3caa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8389f497b263853ebe5c7da700f6a2d2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4fe7ec92fe540d962cf0318df0ae8c8 |
| date |
2003-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/15609193
https://doi.org/10.1007/s10198-003-0175-4 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32127
https://portal.issn.org/resource/ISSN/1618-7598
https://portal.issn.org/resource/ISSN/1618-7601 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11071
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8026
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282448 |